Interojo Co

Interojo Co OCF/Debt

The Operating Cash Flow to Debt Ratio of Interojo Co (119610.KQ) as of Oct 22, 2026 is 59.42 %. In the previous year, Operating Cash Flow to Debt Ratio was 14.42 % — a change of 311.97% (higher).

OCF/Debt

59.42 %

YoY

311.97%

Last updated:

Operating Cash Flow to Debt Ratio of Interojo Co is 2024 59.42 % . Operating Cash Flow to Debt Ratio of Interojo Co was 2023 14.42 % . It decreases by 311.97% higher compared to the previous year.

The Interojo Co OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2017
582.78 KRW
Jan 1, 2018
153.24 KRW
Jan 1, 2019
115.59 KRW
Jan 1, 2020
51.43 KRW
Jan 1, 2021
56.88 KRW
Jan 1, 2022
26.34 KRW
Jan 1, 2023
14.42 KRW
Jan 1, 2024
59.42 KRW
The Interojo Co OCF/Debt history
YEAROCF/DebtYoY
59.42 %+311.97%
14.42 %-45.24%
26.34 %-53.70%
56.88 %+10.60%
51.43 %-55.51%
115.59 %-24.57%
153.24 %-73.70%
582.78 %+49.97%
388.59 %+62.72%
238.81 %+141.13%
99.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Operating Cash Flow to Debt Ratio of Interojo Co is 59.42 % in 2024.

Operating Cash Flow to Debt Ratio of Interojo Co changed from 14.42 % to 59.42 %, representing a 311.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Interojo Co since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Interojo Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Interojo Co

All Key Metrics — Interojo Co